Free Trial

Zenas Biopharma (ZBIO) News Today

Zenas Biopharma logo
$9.23 -1.33 (-12.59%)
As of 05/28/2025 04:00 PM Eastern

Why is Zenas Biopharma Dropping Today?

Shares of Zenas Biopharma, Inc. (NASDAQ: ZBIO) are down as investors react to a wave of securities class action announcements tied to the company’s September 13, 2024 IPO.

Key developments:

  • Multiple law firms—including Bronstein, Gewirtz & Grossman; Rosen Law Firm; Schall Law Firm; The Gross Law Firm; Levi & Korsinsky; and DJS Law Group—have filed or announced class action suits against ZBIO and its officers.
  • Shareholder deadline to seek lead plaintiff status in these suits is June 16, 2025, prompting repeated reminders.
  • Lawsuits allege material misstatements or omissions in ZBIO’s IPO registration statement and prospectus, exposing the company to potential damages.
  • Ongoing litigation raises uncertainty around future legal costs and financial liabilities for ZBIO.
Posted 21m agoAI Generated. May Contain Errors.

ZBIO Latest News

What is Wedbush's Forecast for Zenas Biopharma Q2 Earnings?
Zenas Biopharma Inc stock logo
What is Wedbush's Estimate for Zenas Biopharma Q2 Earnings?
Zenas Biopharma Inc (NASDAQ:ZBIO - Free Report) - Research analysts at Wedbush lifted their Q2 2025 earnings per share estimates for shares of Zenas Biopharma in a report issued on Thursday, May 15th. Wedbush analyst M. Fan now forecasts that the company will earn ($1.03) per share for the quarte
Get Zenas Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.

ZBIO Media Mentions By Week

ZBIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZBIO
News Sentiment

0.04

0.87

Average
Medical
News Sentiment

ZBIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZBIO Articles
This Week

18

14

ZBIO Articles
Average Week

Get Zenas Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZBIO) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners